EMBARGOED UNTIL 3 p.m. CT/4 p.m. ET, Monday, April 1, 2013
DALLAS — Seeing a doctor within a month of an emergency room visit for chest pain significantly reduced the risk of heart attack or death among high risk patients, according to research published the American Heart Association journal Circulation.
Chest pain is the most common reason people go to the emergency room in developed countries and accounts for more than 5 million ER visits each year in the United States.
The study is the first to demonstrate the importance of follow-up care for chest pain patients after leaving the ER, researchers said. High risk patients in this study were those with previously diagnosed heart disease or diabetes.
“Being discharged from the emergency department is reassuring for patients, but it is critical that they follow up with their doctor to reduce their risks of future heart attacks or premature death,” said Dennis T. Ko, M.D., M.Sc., senior author and scientist at the Institute for Clinical Evaluative Sciences, Cardiologist at Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada. “Patients need to advocate for themselves and physicians need to be more diligent about arranging follow-up care.”
Researchers analyzed data on 56,767 adults (average age 66, 53 percent men) in Ontario, Canada, who were diagnosed with chest pain in an emergency room between April 2004 and March 2010; had been previously diagnosed with heart disease or diabetes; and didn’t require additional hospitalization or die within a month. They tracked data for a median 3.7 years and accounted for differences in key patient characteristics such as age, gender, health status and location.
Among the findings:
Patients who didn’t seek follow-up care within a month received the lowest rate of care and had the worst health outcomes — demonstrating the need to improve follow-up with high risk chest pain patients after they’re discharged from the emergency room, Ko said.
The study notes that there are several reasons patients did not receive additional physician follow-up including: patients believing they didn’t need additional care and the lack of a coordinated referral system from the emergency department to physicians who can provide follow-up care.
While there is no cost for seeing a physician at follow-up in the Canadian health care system, the barriers for follow up care could include expense in other countries.
“As physicians, we are often so focused on knowing which drug to prescribe or which test to order that we overlook the fact that many patients fail to get follow-up care to begin with,” Ko said. “We need systems of care that better identify these patients who are at increased risk because getting that follow-up can significantly reduce their risks of heart attack or premature death.”
Because the study focused on high risk patients, the results may not apply to all who have chest pain. Researchers recommend further study that will also investigate economic factors.
Co-authors are: Andrew Czarnecki, M.D.; Alice Chong, B.Sc.; Douglas S. Lee, M.D., Ph.D.; Michael J. Schull, M.D., M.Sc.; Jack V. Tu, M.D., Ph.D.; Ching Lau, M.D.; and Michael E. Farkouh, M.D., M.Sc..
Author disclosures and sources of funding are on the manuscript.
Learn how to Understand Your Risk of Heart Attack
For the latest heart and stroke news, follow us on Twitter: @HeartNews.
Additional resources, including multimedia, are available in the right column of this link: http://newsroom.heart.org/news/post-er-care-for-chest-pain-reduces-risk-of-heart-attack-death?preview=cdad630c4bd657267df5283df5a5ffd6
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.